Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis
Conditions: Hepatitis B; Cirrhosis, Liver; Chronic Liver Disease Interventions: Biological: Heplisav-B Injectable Product, 2-dose regimen; Biological: Heplisav-B Injectable Product, 3-dose regimen Sponsor: Mercy Medical Center Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials